Diagnostyka zmian ogniskowych wątroby z zastosowaniem ultrasonograficznych środków kontrastujących – strategia badania Artykuł przeglądowy
##plugins.themes.bootstrap3.article.sidebar##
Opublikowane:
cze 30, 2021
Słowa kluczowe:
ultrasonograficzne środki kontrastujące, zmiany ogniskowe wątroby
##plugins.themes.bootstrap3.article.main##
Abstrakt
Celem pracy jest przedstawienie techniki i strategii badania ultrasonograficznego z zastosowaniem ultrasonograficznych środków kontrastujących w diagnostyce zmian ogniskowych wątroby w zależności od wskazań i obrazu klinicznego.
##plugins.themes.bootstrap3.article.details##
Jak cytować
Jędrzejczyk , M. (2021). Diagnostyka zmian ogniskowych wątroby z zastosowaniem ultrasonograficznych środków kontrastujących – strategia badania . Medycyna Faktów , 14(2(51), 145-153. https://doi.org/10.24292/01.MF.0221.A
Numer
Dział
Artykuły
Copyright © by Medical Education. All rights reserved.
Bibliografia
1. Dietrich ChF, Nolsøe ChP, Barr RG et al. Guidelines and Good Clinical Practice Recommendations for Contrast Enhanced Ultrasound (CEUS) in the Liver – Update 2020. Ultraschall Med. 2020; 41: 562-85.
2. Friedrich-Rust M, Klopffleisch T, Nierhoff J et al. Contrast-enhanced Ultrasound for the differentiation of benign and malignant focal liver lesions: a meta-analysis. Liver Int. 2013; 33(5): 739-55.
3. Guang Y, Xie L, Ding H et al. Diagnosis value of focal liver lesions with SonoVue(R)-enhanced ultrasound compared with contrast-enhanced computed tomography and contrast-enhanced MRI: a meta-analysis. J Cancer Res Clin Oncol. 2011; 137: 1595-605.
4. Barr RG. Contrast enhanced ultrasound for focal liver lesions: how, accurate is it? Abdom Radiol (NY). 2018; 43: 1128-33.
5. Trillaud H, Bruel JM, Valette PJ et al. Characterization of focal liver lesions with SonoVue-enhanced sonography: international multicenter-study in comparison to CT and MRI. World J Gastroenterol. 2009; 15: 3748-56.
6. Piscaglia F, Bolondi L. The safety of Sonovue in abdominal applications: retrospective analysis of 23188 investigations. Ultrasound Med Biol. 2006; 32: 1369-75.
7. Tang C, Fang K, Guo Y et al. Safety of Sulfur Hexafluoride Microbubbles in Sonography of Abdominal and Superficial Organs: Retrospective Analysis of 30222 Cases. J Ultrasound Med. 2017; 36: 531-8.
8. Dietrich C, Augustiniene R, Batko T et al. European Federation of Societies for Ultrasound in Medicine and Biology (EFSUMB), update on the Pediatric CEUS Registry on Behalf of the “EFSUMB Pediatric CEUS Registry Working Group”. Ultraschall Med. 2021. http://doi.org/10.1055/a-1345-3626.
9. Seitz K, Greis C, Schuler A et al. Frequency of tumor entities among liver tumors of unclear etiology initially detected by sonography in the noncirrhotic or cirrhotic livers of 1349 patients. Results of the DEGUM multicenter study. Ultraschall Med. 2011; 32: 598-603.
10. Chiorean L, Caraiani C, Radzina M et al. Vascular phases in imaging and their role in focal liver lesions assessment. Clin Hemorheol Microcirc. 2015; 62: 299-326.
11. Dietrich CF, Averkiou M, Nielsen MB et al. How to perform Contrast-Enhanced Ultrasound (CEUS). Ultrasound Int Open. 2018; 4: E2-E15.
12. Strobel D, Bernatik T, Blank W et al. Diagnostic accuracy of CEUS in the differential diagnosis of small (≤ 20 mm) and subcentimetric (≤ 10 mm) focal liver lesions in comparison with histology. Results of the DEGUM multicenter trial. Ultraschall Med. 2011; 32: 593-7.
13. Dietrich CF, Ignee A, Greis C et al. Artifacts and pitfalls in contrast-enhanced, ultrasound of the liver. Ultraschall Med. 2014; 35: 108-25.
14. Sporea I, Badea R, Popescu A et al. Contrast-enhanced ultrasound (CEUS), for the evaluation of focal liver lesions – a prospective multicenter study of its usefulness in clinical practice. Ultraschall Med. 2014; 35: 25-66.
15. Corvino A, Catalano O, Corvino F et al. Diagnostic Performance and Confidence of Contrast-Enhanced Ultrasound in the Differential Diagnosis of Cystic and Cysticlike Liver Lesions. Am J Roentgenol. 2017; 209: W119-W27.
16. Dietrich CF, Mertens JC, Braden B et al. Contrast-enhanced ultrasound of histologically proven liver hemangiomas. Hepatology. 2007; 45: 1139-45.
17. Piscaglia F, Venturi A, Mancini M et al. Diagnostic features of real-time contrast-enhanced ultrasound in focal nodular hyperplasia of the liver. Ultraschall Med. 2010; 31: 276-82.
18. Dietrich CF, Tannapfel A, Jang HJ et al. Ultrasound Imaging of Hepatocellular Adenoma Using the New Histology Classification. Ultrasound Med Biol. 2019; 45: 1-10.
19. Liu GJ, Lu MD, Xie XY et al. Real-time contrast-enhanced ultrasound imaging of infected focal liver lesions. J Ultrasound Med. 2008; 27: 657-66.
20. Quaia E, D’Onofrio M, Palumbo A et al. Comparison of contrast-enhanced ultrasonography versus baseline ultrasound and contrast-enhanced computed tomography in metastatic disease of the liver: diagnostic performance and confidence. Eur Radiol. 2006; 16: 1599-609.
21. Jang HJ, Kim TK, Burns PN et al. Enhancement patterns of hepatocellular carcinoma at contrast-enhanced US: comparison with histologic differentiation. Radiology. 2007; 244: 898-906.
22. Strobel D, Seitz K, Blank W et al. Tumor-Specific Vascularization Pattern of Liver Metastasis, Hepatocellular Carcinoma, Hemangioma and Focal Nodular Hyperplasia in the Differential Diagnosis of 1349 Liver Lesions in Contrast-Enhanced Ultrasound (CEUS). Ultraschall Med. 2009; 30: 376-82.
23. Strobel D, Seitz K, Blank W et al. Contrast-enhanced ultrasound for the characterization of focal liver lesions – diagnostic accuracy in clinical practice (DEGUM multicenter trial). Ultraschall Med. 2008; 29: 499-505.
24. Seitz K, Bernatik T, Strobel D et al. Contrast-enhanced ultrasound (CEUS) for the characterization of focal liver lesions in clinical practice (DEGUM Multicenter Trial): CEUS vs. MRI – a prospective comparison in 269 patients. Ultraschall Med. 2010; 31: 492-9.
25. Sandrose SW, Karstrup S, Gerke O et al. Contrast Enhanced Ultrasound in CT-undetermined Focal Liver Lesions. Ultrasound Int Open. 2016; 2: E129-E35.
26. Muhi A, Ichikawa T, Motosugi U et al. Diagnosis of colorectal hepatic metastases: comparison of contrast-enhanced CT, contrast-enhanced US, superparamagnetic iron oxide-enhanced MRI, and gadoxetic acidenhanced MRI. J Magn Reson Imaging. 2011; 34: 326-35.
27. Zheng SG, Xu HX, Liu LN. Management of hepatocellular carcinoma: The role of contrast-enhanced ultrasound. World J Radiol. 2014; 6: 7-14.
28. Lyshchik A, Kono Y, Dietrich CF et al. Contrast-enhanced ultrasound of the liver: technical and lexicon recommendations from the ACR CEUS LI-RADS working group. Abdom Radiol (NY). 2018; 43: 861-79.
29. Kim TK, Noh SY, Wilson SR et al. Contrast-enhanced ultrasound (CEUS) liver imaging reporting and data system (LI-RADS) 2017 – a review of important differences compared to the CT/MRI system. Clin Mol Hepatol. 2017; 23: 280-9.
30. Schellhaas B, Hammon M, Strobel D et al. Interobserver and intermodality agreement of standardized algorithms for non-invasive diagnosis of hepatocellular carcinoma in high-risk patients: CEUS-LI-RADS versus MRI-LI-RADS. Eur Radiol. 2018; 28: 4254-64.
31. Schellhaas B, Gortz RS, Pfeifer L et al. Diagnostic accuracy of contrastenhanced ultrasound for the differential diagnosis of hepatocellular carcinoma: ESCULAP versus CEUS-LI-RADS. Eur J Gastroenterol Hepatol. 2017; 29: 1036-44.
32. Leoni S, Piscaglia F, Golfieri R et al. The impact of vascular and nonvascular findings on the noninvasive diagnosis of small hepatocellular carcinoma based on the EASL and AASLD criteria. Am J Gastroenterol. 2010; 105: 599-609.
33. Iavarone M, Sangiovanni A, Forzenigo LV et al. Diagnosis of hepatocellular carcinoma in cirrhosis by dynamic contrast imaging: the importance of tumor cell differentiation. Hepatology. 2010; 52: 1723-30.
2. Friedrich-Rust M, Klopffleisch T, Nierhoff J et al. Contrast-enhanced Ultrasound for the differentiation of benign and malignant focal liver lesions: a meta-analysis. Liver Int. 2013; 33(5): 739-55.
3. Guang Y, Xie L, Ding H et al. Diagnosis value of focal liver lesions with SonoVue(R)-enhanced ultrasound compared with contrast-enhanced computed tomography and contrast-enhanced MRI: a meta-analysis. J Cancer Res Clin Oncol. 2011; 137: 1595-605.
4. Barr RG. Contrast enhanced ultrasound for focal liver lesions: how, accurate is it? Abdom Radiol (NY). 2018; 43: 1128-33.
5. Trillaud H, Bruel JM, Valette PJ et al. Characterization of focal liver lesions with SonoVue-enhanced sonography: international multicenter-study in comparison to CT and MRI. World J Gastroenterol. 2009; 15: 3748-56.
6. Piscaglia F, Bolondi L. The safety of Sonovue in abdominal applications: retrospective analysis of 23188 investigations. Ultrasound Med Biol. 2006; 32: 1369-75.
7. Tang C, Fang K, Guo Y et al. Safety of Sulfur Hexafluoride Microbubbles in Sonography of Abdominal and Superficial Organs: Retrospective Analysis of 30222 Cases. J Ultrasound Med. 2017; 36: 531-8.
8. Dietrich C, Augustiniene R, Batko T et al. European Federation of Societies for Ultrasound in Medicine and Biology (EFSUMB), update on the Pediatric CEUS Registry on Behalf of the “EFSUMB Pediatric CEUS Registry Working Group”. Ultraschall Med. 2021. http://doi.org/10.1055/a-1345-3626.
9. Seitz K, Greis C, Schuler A et al. Frequency of tumor entities among liver tumors of unclear etiology initially detected by sonography in the noncirrhotic or cirrhotic livers of 1349 patients. Results of the DEGUM multicenter study. Ultraschall Med. 2011; 32: 598-603.
10. Chiorean L, Caraiani C, Radzina M et al. Vascular phases in imaging and their role in focal liver lesions assessment. Clin Hemorheol Microcirc. 2015; 62: 299-326.
11. Dietrich CF, Averkiou M, Nielsen MB et al. How to perform Contrast-Enhanced Ultrasound (CEUS). Ultrasound Int Open. 2018; 4: E2-E15.
12. Strobel D, Bernatik T, Blank W et al. Diagnostic accuracy of CEUS in the differential diagnosis of small (≤ 20 mm) and subcentimetric (≤ 10 mm) focal liver lesions in comparison with histology. Results of the DEGUM multicenter trial. Ultraschall Med. 2011; 32: 593-7.
13. Dietrich CF, Ignee A, Greis C et al. Artifacts and pitfalls in contrast-enhanced, ultrasound of the liver. Ultraschall Med. 2014; 35: 108-25.
14. Sporea I, Badea R, Popescu A et al. Contrast-enhanced ultrasound (CEUS), for the evaluation of focal liver lesions – a prospective multicenter study of its usefulness in clinical practice. Ultraschall Med. 2014; 35: 25-66.
15. Corvino A, Catalano O, Corvino F et al. Diagnostic Performance and Confidence of Contrast-Enhanced Ultrasound in the Differential Diagnosis of Cystic and Cysticlike Liver Lesions. Am J Roentgenol. 2017; 209: W119-W27.
16. Dietrich CF, Mertens JC, Braden B et al. Contrast-enhanced ultrasound of histologically proven liver hemangiomas. Hepatology. 2007; 45: 1139-45.
17. Piscaglia F, Venturi A, Mancini M et al. Diagnostic features of real-time contrast-enhanced ultrasound in focal nodular hyperplasia of the liver. Ultraschall Med. 2010; 31: 276-82.
18. Dietrich CF, Tannapfel A, Jang HJ et al. Ultrasound Imaging of Hepatocellular Adenoma Using the New Histology Classification. Ultrasound Med Biol. 2019; 45: 1-10.
19. Liu GJ, Lu MD, Xie XY et al. Real-time contrast-enhanced ultrasound imaging of infected focal liver lesions. J Ultrasound Med. 2008; 27: 657-66.
20. Quaia E, D’Onofrio M, Palumbo A et al. Comparison of contrast-enhanced ultrasonography versus baseline ultrasound and contrast-enhanced computed tomography in metastatic disease of the liver: diagnostic performance and confidence. Eur Radiol. 2006; 16: 1599-609.
21. Jang HJ, Kim TK, Burns PN et al. Enhancement patterns of hepatocellular carcinoma at contrast-enhanced US: comparison with histologic differentiation. Radiology. 2007; 244: 898-906.
22. Strobel D, Seitz K, Blank W et al. Tumor-Specific Vascularization Pattern of Liver Metastasis, Hepatocellular Carcinoma, Hemangioma and Focal Nodular Hyperplasia in the Differential Diagnosis of 1349 Liver Lesions in Contrast-Enhanced Ultrasound (CEUS). Ultraschall Med. 2009; 30: 376-82.
23. Strobel D, Seitz K, Blank W et al. Contrast-enhanced ultrasound for the characterization of focal liver lesions – diagnostic accuracy in clinical practice (DEGUM multicenter trial). Ultraschall Med. 2008; 29: 499-505.
24. Seitz K, Bernatik T, Strobel D et al. Contrast-enhanced ultrasound (CEUS) for the characterization of focal liver lesions in clinical practice (DEGUM Multicenter Trial): CEUS vs. MRI – a prospective comparison in 269 patients. Ultraschall Med. 2010; 31: 492-9.
25. Sandrose SW, Karstrup S, Gerke O et al. Contrast Enhanced Ultrasound in CT-undetermined Focal Liver Lesions. Ultrasound Int Open. 2016; 2: E129-E35.
26. Muhi A, Ichikawa T, Motosugi U et al. Diagnosis of colorectal hepatic metastases: comparison of contrast-enhanced CT, contrast-enhanced US, superparamagnetic iron oxide-enhanced MRI, and gadoxetic acidenhanced MRI. J Magn Reson Imaging. 2011; 34: 326-35.
27. Zheng SG, Xu HX, Liu LN. Management of hepatocellular carcinoma: The role of contrast-enhanced ultrasound. World J Radiol. 2014; 6: 7-14.
28. Lyshchik A, Kono Y, Dietrich CF et al. Contrast-enhanced ultrasound of the liver: technical and lexicon recommendations from the ACR CEUS LI-RADS working group. Abdom Radiol (NY). 2018; 43: 861-79.
29. Kim TK, Noh SY, Wilson SR et al. Contrast-enhanced ultrasound (CEUS) liver imaging reporting and data system (LI-RADS) 2017 – a review of important differences compared to the CT/MRI system. Clin Mol Hepatol. 2017; 23: 280-9.
30. Schellhaas B, Hammon M, Strobel D et al. Interobserver and intermodality agreement of standardized algorithms for non-invasive diagnosis of hepatocellular carcinoma in high-risk patients: CEUS-LI-RADS versus MRI-LI-RADS. Eur Radiol. 2018; 28: 4254-64.
31. Schellhaas B, Gortz RS, Pfeifer L et al. Diagnostic accuracy of contrastenhanced ultrasound for the differential diagnosis of hepatocellular carcinoma: ESCULAP versus CEUS-LI-RADS. Eur J Gastroenterol Hepatol. 2017; 29: 1036-44.
32. Leoni S, Piscaglia F, Golfieri R et al. The impact of vascular and nonvascular findings on the noninvasive diagnosis of small hepatocellular carcinoma based on the EASL and AASLD criteria. Am J Gastroenterol. 2010; 105: 599-609.
33. Iavarone M, Sangiovanni A, Forzenigo LV et al. Diagnosis of hepatocellular carcinoma in cirrhosis by dynamic contrast imaging: the importance of tumor cell differentiation. Hepatology. 2010; 52: 1723-30.